Related Experiment Video
Updated: May 29, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Efficacy and Safety of Ciprofol versus Propofol for Tracheal Intubation in Pediatric Patients Undergoing Laparoscopic
Jieze Pan1,2,3, Tianhao Zhong1,2,3, Yiwen Lv1,2,3
1Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
Insights
Ciprofol (0.782 mg/kg) is as effective as propofol for pediatric anesthesia during tracheal intubation, showing non-inferiority with fewer adverse events and less injection pain.
Area of Science:
- Anesthesiology
- Pediatric Anesthesia
- Pharmacology
Background:
- Ciprofol, a novel GABAA receptor agonist, presents a potential alternative for pediatric anesthesia.
- Evaluating ciprofol's efficacy and safety for tracheal intubation in children is crucial.
Purpose of the Study:
- Determine the effective dose 95 (ED95) of ciprofol for tracheal intubation in pediatric patients.
- Compare the efficacy and safety of ciprofol versus propofol for pediatric anesthesia during laparoscopic hernia repair.
Main Methods:
- A dose-finding phase determined the ED95 of ciprofol using a biased coin design up-and-down sequential method.
- A non-inferiority phase randomly assigned 80 children to receive either ciprofol (0.782 mg/kg) or propofol (4 mg/kg) for induction.
- Tracheal intubation conditions, adverse events, hemodynamics, and recovery times were assessed.
Main Results:
- The ED95 of ciprofol for tracheal intubation was established at 0.782 mg/kg.
- Ciprofol demonstrated non-inferiority to propofol, with excellent intubation conditions achieved in 95.0% of the ciprofol group versus 89.7% in the propofol group.
- Adverse events were significantly lower with ciprofol (17.5%) compared to propofol (76.9%), notably reduced injection pain (2.5% vs. 38.5%).
Conclusions:
- Ciprofol at 0.782 mg/kg is effective for pediatric tracheal intubation, achieving non-inferiority to propofol.
- Ciprofol offers a favorable safety profile, including reduced injection pain and more stable hemodynamics compared to propofol.
- Ciprofol represents a promising alternative anesthetic agent for pediatric surgical procedures.
Background:
Ciprofol, a novel GABAA receptor agonist, might be an alternative for pediatric anesthesia. This study aimed to determine the ED95 of ciprofol, and compare its efficacy and safety with propofol for tracheal intubation in pediatric patients undergoing laparoscopic hernia repair.
Patients And Methods:
Of 166 screened children, 120 were enrolled: 40 patients to dose-finding phase to determine the ED95 of ciprofol by biased coin design up-and-down sequential method, and the remaining 80 patients to non-inferiority comparison phase. 80 patients were randomly allocated in 1:1 ratio to receive ciprofol (0.782 mg/kg) or propofol (4 mg/kg) for induction, combined with fentanyl and cisatracurium. Primary outcome was proportion of patients who achieved an excellent grade for tracheal intubation conditions. Secondary outcomes included incidence of adverse events, hemodynamic parameters, loss of consciousness time, and PACU recovery time.
Results:
(1) ED95 of ciprofol for tracheal intubation in children undergoing laparoscopic hernia repair was 0.782 mg/kg (95% CI: 0.75-0.795 mg/kg). (2) An excellent grade for tracheal intubation conditions was achieved in 38 (95.0%) children in ciprofol group versus 35 (89.7%) children in propofol group in per-protocol analysis (rate difference 5.3%, 95% CI -4.14-14.73%). In intention-to-treat analysis, excellent grade rate in propofol group was 90.0% (36/40), with a rate difference of 5.0% (95% CI -4.1%-14.9%). Non-inferiority of ciprofol to propofol was confirmed in both analyses. Adverse events occurred in 7 (17.5%) children receiving ciprofol and 30 (76.9%) receiving propofol. Injection pain was significantly lower with ciprofol (2.5% vs. 38.5%).
Conclusion:
In healthy, non-obese children aged 3-6 years undergoing laparoscopic hernia repair, ED95 of ciprofol for tracheal intubation was 0.782 mg/kg. Ciprofol (0.782 mg/kg) demonstrated non-inferiority to propofol (4 mg/kg) in excellent tracheal intubation conditions, with lower injection pain and more stable hemodynamics.
Related Concept Videos
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
Parenteral Anesthetics: Overview
Endotracheal Intubation I: Procedure
The ET tube comprises various components, including a standard adaptor to attach a bag-valve-mask (BVM) or ventilator, a cuff, a pilot balloon, and radiopaque markings along its length to measure the insertion distance. The tube sizes...